Pharmacological aspects of albumin as a niche product in the intensive care unit

Critical Care Medicine

Volumn 33, Issue 7, 2005, Pages 1667-1669

  Martin, Greg S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Antioxidant; Blood proteins; Colloid; Critical illness; Osmotic pressure

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIOXIDANT; BILIRUBIN; CYSTEINE; DIURETIC AGENT; FREE RADICAL; NITRIC OXIDE; PLASMA PROTEIN; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; COLLOID; CRITICAL ILLNESS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LIVER FAILURE; MORTALITY; MULTIPLE ORGAN FAILURE; OSMOTIC PRESSURE; PLASMA; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; SURVIVAL RATE;

EID: 22144455727     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000170175.18540.CD     Document Type: Editorial

References (22)

1. Martin GS, Lewis CA: Fluid management in shock. Semin Respir Crit Care Med 2004; 25:683-694
2. The American Thoracic Society Colloid Working Group. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004; 170:1247-1259
3. von Hoegen I, Waller C: Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001; 29:994-996
4. Velanovich V: Crystalloid versus colloid fluid resuscitation: A meta-analysis of mortality. Surgery 1989; 105:65-71
5. Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomized trials. BMJ 1998; 316:961-964
6. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: Systematic review of randomized controlled trials. BMJ 1998; 317:235-240
7. Choi PT, Yip G, Quinonez LG, et al: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27:200-210
8. Wilkes MM, Navickis RJ: Patient survival after human albumin administration. A metaanalysis of randomized, controlled trials. Ann Intern Med 2001; 135:149-164
9. Finfer S, Bellomo R, Boyce N, et al: SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
10. Sort P, Navasa M, Arroyo V, et al: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409
11. Gentilini P, Casini-Raggi V, Di Fiore G, et al: Albumin improves the response to diuretics in patients with cirrhosis and ascites: Results of a randomized, controlled trial. J Hepatol 1999; 30:639-645
12. Gines P, Cardenas A, Arroyo V, et al: Management of cirrhosis and ascites. N Engl J Med 2004; 350:1646-1654
13. Guo LM, Liû JY, Xu DZ, et al: Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003; 23(Suppl 3):16-20
14. Sedrakyan A, Gondek K, Paltiel D, et al: Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003; 123:1853-1857
15. Martin GS, Mangialardi RJ, Wheeler AP, et al: Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182
16. Martin GS, Moss M, Wheeler AP, et al: A randomized controlled trial of furosemide with or without albumin in hypoproteinemic acute lung injury patients. Crit Care Med, In Press
17. Reeves JH, Butt WW, Shann F, et al: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999; 27:2096-2104
18. Bar-Or D, Bar-Or R, Rael LT. et al: Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005; 33:1638-1641
19. Quinlan GJ, Margarson MP, Mumby S, et al: Administration of albumin to patients with sepsis syndrome: A possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998; 95:459-465
20. Quinlan GJ, Mumby S, Martin GS, et al: Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32:755-759
21. Quinlan GJ, Coudray C, Hubbard A, et al: Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure. J Pharm Sci 1992; 81:611-614
22. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367